Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
editorial
. 1982 Jun 19;284(6332):1817–1818. doi: 10.1136/bmj.284.6332.1817-a

Toxicity of pertussis vaccine.

N W Preston
PMCID: PMC1498796  PMID: 6805711

Full text

PDF
1817

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bannatyne R. M., Cheung R. Reducing the endotoxic activity of pertussis vaccine. J Hyg (Lond) 1981 Dec;87(3):377–381. doi: 10.1017/s0022172400069618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cameron J. The potency of whooping cough (pertussis) vaccines in Canada. J Biol Stand. 1980;8(4):297–302. doi: 10.1016/s0092-1157(80)80007-2. [DOI] [PubMed] [Google Scholar]
  3. Cody C. L., Baraff L. J., Cherry J. D., Marcy S. M., Manclark C. R. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics. 1981 Nov;68(5):650–660. [PubMed] [Google Scholar]
  4. Harris F., Bush G., Lewis M. Death of infants after triple vaccine. Lancet. 1979 Sep 1;2(8140):473–473. [PubMed] [Google Scholar]
  5. Manclark C. R. Pertussis vaccine research. Bull World Health Organ. 1981;59(1):9–15. [PMC free article] [PubMed] [Google Scholar]
  6. Meade T. W. Pertussis vaccine. Br Med J (Clin Res Ed) 1981 Jul 4;283(6283):59–60. doi: 10.1136/bmj.283.6283.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Miller D. L., Ross E. M., Alderslade R., Bellman M. H., Rawson N. S. Pertussis immunisation and serious acute neurological illness in children. Br Med J (Clin Res Ed) 1981 May 16;282(6276):1595–1599. doi: 10.1136/bmj.282.6276.1595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Morse S. I. Biologically active components and properties of Bordetella pertussis. Adv Appl Microbiol. 1976;20:9–26. doi: 10.1016/s0065-2164(08)70106-0. [DOI] [PubMed] [Google Scholar]
  9. Preston N. W., Garrity P. Histamine-sensitising factor of Bordetella pertussis differentiated from immunogens by neutralisation and passive protection tests. J Pathol Bacteriol. 1967 Apr;93(2):483–492. doi: 10.1002/path.1700930209. [DOI] [PubMed] [Google Scholar]
  10. Preston N. W., Mackay R. I., Bamford F. N., Crofts J. E., Burland W. L. Pertussis agglutinins in vaccinated children: better response with adjuvant. J Hyg (Lond) 1974 Aug;73(1):119–125. doi: 10.1017/s0022172400023913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Preston N. W. Prevalent serotypes of Bordetella pertussis in non-vaccinated communities. J Hyg (Lond) 1976 Aug;77(1):85–91. doi: 10.1017/s0022172400055546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Preston N. W. Whooping-cough in Hertfordshire. Lancet. 1979 Sep 22;2(8143):645–645. doi: 10.1016/s0140-6736(79)91711-2. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES